Paris, France and Camberley, UK – 8 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its test for COVID-19 (Z-Path COVID-19-CE IVD) has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process. The test will be eligible
Visit PageYear: 2020
Mise à jour sur le test pour le coronavirus
Paris, France et Camberley, Royaume-Uni – 6 avril 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce que le Centre National de Référence des Virus des Infections Respiratoires (dont la grippe) de l’Institut Pasteur, le centre de recherche biomédicale de renommée internationale ayant pour objectif d’améliorer la santé
Visit PageCOVID-19 diagnostic regulatory update
Paris, France and Camberley, UK – 6 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the CNR (Centre National de Référence des Virus des Infections Respiratoires (dont la grippe)) of the Institut Pasteur, an internationally renowned centre for biomedical research with a goal of improving public
Visit Page